Target intelligence / Profile preview

Urinary drainage process

01

Overview

The urinary drainage process encompasses the physiological mechanisms for transporting urine from the kidneys to the bladder via peristaltic contractions in the ureters, storage in the compliant bladder, and coordinated expulsion during micturition. Urine boluses are propelled unidirectionally through ureteral smooth muscle layers, protected from reflux by the ureterovesical junction and trigone geometry, with pacemaker cells generating calcium-dependent contractions.[1] The bladder detrusor muscle relaxes during filling to accommodate up to 300-500 mL at low pressure via beta-3 adrenergic signaling, while internal and external urethral sphincters maintain continence.[1][2][3] Voiding is initiated by pontine micturition center activation, triggering parasympathetic detrusor contraction, nitric oxide-mediated internal sphincter relaxation, and pudendal nerve inhibition of the external sphincter.[1][3] Disruptions contribute to conditions like ureteral obstruction, overactive bladder, or incontinence, often linked to urothelial defects or neural dysregulation.[1] Pharmacologic interventions target smooth muscle calcium handling or autonomic receptors to facilitate drainage or control symptoms, though not the process itself as a discrete molecular target.[1]

Other names
Urine transportMicturitionVoidingUrinary excretion
02

Mechanism of action

Calcium channel blockade to enhance ureteral smooth muscle relaxation and aid stone passage; Beta-3 adrenergic receptor agonism to promote detrusor relaxation during filling; Muscarinic receptor antagonism to reduce detrusor contraction; Alpha-1 adrenergic antagonism to relax internal urethral sphincter

03

Biological functions

Peristaltic transport of urine via uretersBladder storage and accommodationCoordinated expulsion via detrusor contraction and sphincter relaxation
04

Disease associations

Urinary tract obstructionVesicoureteral refluxUrinary incontinenceOveractive bladderUrinary retention
05

Safety considerations

Ureteral decompensation from prolonged obstructionVesicoureteral reflux from trigone damageBladder overdistension leading to retentionHypertension or hypotension from adrenergic modulators
06

Interacting drugs

Nifedipine (calcium channel blocker for ureteral relaxation)

3 more in the full profile.

Beyond the preview

Go deeper on Urinary drainage process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urinary drainage process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call